Michael Lawrence Traub

ND, DHANP, FABNO The majority of patients with cancer choose our services in combination with conventional cancer treatment. Naturopathic medicine prevents or alleviates the side effects of conventional treatments, while at the same time enhancing their efficacy. Naturopathic therapies are also directed toward strengthening the immune response to cancer.

Dr. Traub is board certified in naturopathic oncology by the American Board of Naturopathic Oncology (ABNO), and is a former member of the ABNO Board of Medical Examiners and the Oncology Association of Naturopathic Physicians (OncANP) . For more information about ABNO and the OncANP, see www.oncanp.org.

In 2015 two naturopathic medical colleges, the Canadian College of Naturopathic Medicine and Bastyr University, partnered to develop a naturopathic oncology clinical research site consortium consisting of 12 North American clinics that provide cutting edge naturopathic oncology, typically complementary to standard conventional therapies to treat patients with advanced cancer. The Canadian/U.S. Integrative Oncology Study (CUSIOS) began enrolling and following 398 advanced cancer patients receiving care in North American advanced naturopathic oncology clinics. The goal of this study was to obtain 3-year survival data on patients receiving advanced naturopathic oncology treatments and compare to U.S. SEER survival outcomes (ClinicalTrials.gov Identifier: NCT02494037). Dr. Traub’s clinic was one of the 12 participating in this study.